Tesaro (Tesaro) Days Inventory : 598.74 (As of Sep. 2018)

View and export this data going back to 2012. Start your Free Trial

What is Tesaro Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Tesaro's Average Total Inventories for the three months ended in Sep. 2018 was $98.1 Mil. Tesaro's Cost of Goods Sold for the three months ended in Sep. 2018 was $15.0 Mil. Hence, Tesaro's Days Inventory for the three months ended in Sep. 2018 was 598.74.

The historical rank and industry rank for Tesaro's Days Inventory or its related term are showing as below:

TSRO's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 192.335
* Ranked among companies with meaningful Days Inventory only.

Tesaro's Days Inventory increased from Sep. 2017 (481.37) to Sep. 2018 (598.74). It might indicate that Tesaro's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tesaro's Inventory Turnover for the three months ended in Sep. 2018 was 0.15.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tesaro's Inventory-to-Revenue for the three months ended in Sep. 2018 was 1.52.

Tesaro Days Inventory Historical Data

The historical data trend for Tesaro's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tesaro Days Inventory Chart

Tesaro Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Days Inventory

Get a 7-Day Free Trial

1,506.31

927.22

280.30

Tesaro Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Days Inventory	Get a 7-Day Free Trial															481.37	153.25	528.25	491.93	598.74

Competitive Comparison of Tesaro's Days Inventory

For the Biotechnology subindustry, Tesaro's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tesaro's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tesaro's Days Inventory distribution charts can be found below:

* The bar in red indicates where Tesaro's Days Inventory falls into.

Tesaro Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tesaro's Days Inventory for the fiscal year that ended in Dec. 2017 is calculated as

	Days Inventory (A: Dec. 2017 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2016 )	+	Total Inventories (A: Dec. 2017 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2017 )	*	Days in Period
=	( (14.7	+	57.939)	/	2 )	/	47.295	*	365
=	36.3195					/	47.295	*	365
=	280.30

Tesaro's Days Inventory for the quarter that ended in Sep. 2018 is calculated as:

	Days Inventory (Q: Sep. 2018 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2018 )	+	Total Inventories (Q: Sep. 2018 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2018 )	*	Days in Period
=	( (87.406	+	108.822)	/	2 )	/	14.953	*	365 / 4
=	98.114					/	14.953	*	365 / 4
=	598.74

Tesaro (NAS:TSRO) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tesaro's Inventory Turnover for the three months ended in Sep. 2018 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	14.953	/	98.114
	=	0.15

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tesaro's Inventory to Revenue for the three months ended in Sep. 2018 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	98.114	/	64.399
	=	1.52

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Tesaro Days Inventory Related Terms

Thank you for viewing the detailed overview of Tesaro's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Tesaro (Tesaro) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tesaro Inc (NAS:TSRO) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.tesarobio.com

Tesaro is an oncology-focused biopharmaceutical company with a focus on developing treatments for cancer. Upon successful development and regulatory approval of any of its product candidates, the company intends to pursue commercialization in key product markets, including North America, Europe, and China. Tesaro is currently focused on commercializing products directly in North America, and directly or in partnership with established companies in Europe and China. The company's strategy is to identify, acquire, and develop promising drug candidates, and to commercialize cancer therapeutics that are potentially safer and more effective than existing treatments.

Executives

Mary Lynne Hedley	director, officer: President & COO	C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Kavita Patel	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Huber Martin H. Jr.	officer: SVP & Chief Medical Officer	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Moulder Leon O Jr	director, officer: Chief Executive Officer	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
James O Armitage	director	C/O TESARO, INC., 1000 WINTER ST., SUITE 3300, WALTHAM MA 02451
Timothy R Pearson	officer: Exec. VP, CFO	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Garry A Nicholson	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Grant C. Bogle	officer: Sr. VP, Chief Commercial Ofc	C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Nea Partners 13, Limited Partnership	10 percent owner	1119 ST. PAUL STREET, BALTIMORE MD 21202
Nea 13 Gp, Ltd	10 percent owner	1119 ST. PAUL STREET, BALTIMORE MD 21202
New Enterprise Associates 13 Lp	10 percent owner	1119 ST PAUL STREET, BALTIMORE MD 21202
Collier Earl M Jr	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Beth C Seidenberg	director
Joseph L Farmer	officer: Sr VP, Gen Counsel & Secretary	C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Patrick J Kerins	10 percent owner